The pharmaceuticals, medicinal chemicals, seasonally adjusted index in the Czech Republic has reached 172.9, signifying a 4.8 (2.9%) increase compared to 2023 Q4.
Pharmaceuticals, medicinal chemicals, seasonally adjusted index in the Czech Republic
No matching regions
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to the Czech Republic
Pharmaceuticals, medicinal chemicals
More indicators for the Czech Republic
Czech Republic Pharmaceuticals, medicinal chemicals between 2005 Q1 and 2024 Q1
Period | Pharmaceuticals, medicinal chemicals | Change |
---|---|---|
2024 Q1 | 172.9 | +4.8 |
2023 Q4 | 168.1 | -0.5 |
2023 Q3 | 168.6 | -17.1 |
2023 Q2 | 185.7 | +18.4 |
2023 Q1 | 167.3 | +3.9 |
2022 Q4 | 163.4 | -4.5 |
2022 Q3 | 167.9 | +11.9 |
2022 Q2 | 156.0 | -2.3 |
2022 Q1 | 158.3 | +1.7 |
2021 Q4 | 156.6 | +6.7 |
2021 Q3 | 149.9 | +2.8 |
2021 Q2 | 147.1 | -6.2 |
2021 Q1 | 153.3 | -1.9 |
2020 Q4 | 155.2 | +13.1 |
2020 Q3 | 142.1 | -2.1 |
2020 Q2 | 144.2 | -1.5 |
2020 Q1 | 145.7 | -2.4 |
2019 Q4 | 148.1 | +1.2 |
2019 Q3 | 146.9 | +7.4 |
2019 Q2 | 139.5 | +3.3 |
2019 Q1 | 136.2 | +13.0 |
2018 Q4 | 123.2 | -0.9 |
2018 Q3 | 124.1 | +7.1 |
2018 Q2 | 117.0 | -1.8 |
2018 Q1 | 118.8 | +7.9 |
2017 Q4 | 110.9 | -6.2 |
2017 Q3 | 117.1 | -5.3 |
2017 Q2 | 122.4 | +15.7 |
2017 Q1 | 106.7 | +1.4 |
2016 Q4 | 105.3 | +0.1 |
2016 Q3 | 105.2 | +0.3 |
2016 Q2 | 104.9 | +6.6 |
2016 Q1 | 98.3 | -8.5 |
2015 Q4 | 106.8 | +7.1 |
2015 Q3 | 99.7 | +3.5 |
2015 Q2 | 96.2 | -1.1 |
2015 Q1 | 97.3 | +2.1 |
2014 Q4 | 95.2 | +2.9 |
2014 Q3 | 92.3 | +5.9 |
2014 Q2 | 86.4 | -12.6 |
2014 Q1 | 99.0 | +3.5 |
2013 Q4 | 95.5 | -4.1 |
2013 Q3 | 99.6 | +13.4 |
2013 Q2 | 86.2 | -2.5 |
2013 Q1 | 88.7 | +2.3 |
2012 Q4 | 86.4 | -0.4 |
2012 Q3 | 86.8 | +2.2 |
2012 Q2 | 84.6 | -5.6 |
2012 Q1 | 90.2 | -0.1 |
2011 Q4 | 90.3 | -1.2 |
2011 Q3 | 91.5 | +0.6 |
2011 Q2 | 90.9 | -3.2 |
2011 Q1 | 94.1 | +1.0 |
2010 Q4 | 93.1 | -0.6 |
2010 Q3 | 93.7 | +4.3 |
2010 Q2 | 89.4 | -1.2 |
2010 Q1 | 90.6 | +5.9 |
2009 Q4 | 84.7 | +3.0 |
2009 Q3 | 81.7 | +3.9 |
2009 Q2 | 77.8 | -4.1 |
2009 Q1 | 81.9 | -3.0 |
2008 Q4 | 84.9 | -3.2 |
2008 Q3 | 88.1 | +0.9 |
2008 Q2 | 87.2 | -2.8 |
2008 Q1 | 90.0 | +2.5 |
2007 Q4 | 87.5 | -2.8 |
2007 Q3 | 90.3 | +1.2 |
2007 Q2 | 89.1 | -4.7 |
2007 Q1 | 93.8 | +2.7 |
2006 Q4 | 91.1 | +2.6 |
2006 Q3 | 88.5 | +6.2 |
2006 Q2 | 82.3 | -1.8 |
2006 Q1 | 84.1 | +1.8 |
2005 Q4 | 82.3 | +2.6 |
2005 Q3 | 79.7 | +3.7 |
2005 Q2 | 76.0 | +1.3 |
2005 Q1 | 74.7 |